1,259
edits
Changes
Jump to navigation
Jump to search
Line 20:
Line 20: − +
→10/6 Summary
==10/6 Summary==
==10/6 Summary==
*Pitched multi-centre trial to Brandon. E-mailed slides in .ppt format to Nina.
*Pitched multi-centre trial to Brandon. E-mailed slides in .ppt format to Nina.
*Met w/ Norm about depression research (Brian Mickey and Grace Lee) and promotion requirements (Harriet Hopf). Ketamine may have an active metabolite that sticks around, explaining its long lasting effects (Nature paper).
*Met w/ Norm about depression research (Brian Mickey and Grace Lee) and promotion requirements (Harriet Hopf). Ketamine may have an active metabolite that sticks around, explaining its long lasting effects ([https://scholar.googleusercontent.com/scholar.bib?q=info:oxmvfF2RMfcJ:scholar.google.com/&output=citation&scisdr=CiBKb9IEEIjgixuUERc:ACTRDVEAAAAAas-SCRfDvqsYSFStZqKmI5mpZP0&scisig=ACTRDVEAAAAAas-SCWl_hrwNxs7LrCdW_sSZWZk&scisf=4&ct=citation&cd=-1&hl=en Nature paper]).
*Lit review of Yohimbine and Naloxone effects on EEG.
*Lit review of Yohimbine and Naloxone effects on EEG.
*Dug through supplement of 2026 A&A paper to find which anesthetics are most selective for which receptors ''in vitro''.
*Dug through supplement of 2026 A&A paper to find which anesthetics are most selective for which receptors ''in vitro''.